These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2617480)

  • 21. Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity.
    Donati MB; Falanga A; Consonni R; Alessio MG; Bassan R; Buelli M; Borin L; Catani L; Pogliani E; Gugliotta L
    Thromb Haemost; 1990 Aug; 64(1):11-6. PubMed ID: 2274915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as a new tumor marker.
    Gordon SG; Cross BA
    Cancer Res; 1990 Oct; 50(19):6229-34. PubMed ID: 2169340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cancer procoagulant activity in cases of esophageal, stomach and colorectal cancer considering progression degree and histological type of cancer].
    Kozuszko B; Skrzydlewski Z; Sulkowska M; Snarska J; Kozłowski M; Skrzydlewska E; Zalewski B
    Pol Merkur Lekarski; 2001 Sep; 11(63):218-20. PubMed ID: 11761814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Procoagulant activity of gastric, colorectal, and renal cancer is factor VII-dependent.
    Szczepański M; Bardadin K; Zawadzki J; Pypno W
    J Cancer Res Clin Oncol; 1988; 114(5):519-22. PubMed ID: 3182913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic significance of cancer procoagulant activity in colorectal cancer].
    Kozuszko B; Skrzydlewski Z; Famulski W
    Pol Merkur Lekarski; 2000 Mar; 8(45):127-8. PubMed ID: 10870414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of blood coagulation and the activity of cancer procoagulant (EC 3.4.22.26) in breast cancer patients.
    Mielicki WP; Tenderenda M; Rutkowski P; Chojnowski K
    Cancer Lett; 1999 Nov; 146(1):61-6. PubMed ID: 10656610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procoagulant activity of human stomach and colon cancers.
    Mielicki W; Serwa J; Kurzawinski T; Wierzbicki R
    Oncology; 1990; 47(4):299-302. PubMed ID: 2367056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer procoagulant--CP.
    Rucińska M; Gacko M; Skrzydlewski Z
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():110-7. PubMed ID: 9337529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cancer procoagulant (CP)].
    Szajda SD; Darewicz B; Gorzel M; Zalewska B; Skrzydlewski Z; Kudelski J; Domel T
    Przegl Lek; 2005; 62(3):169-72. PubMed ID: 16171148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells.
    Dvorak HF; Van DeWater L; Bitzer AM; Dvorak AM; Anderson D; Harvey VS; Bach R; Davis GL; DeWolf W; Carvalho AC
    Cancer Res; 1983 Sep; 43(9):4434-42. PubMed ID: 6347372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New immunocapture enzyme (ICE) assay for quantification of cancer procoagulant activity: studies of inhibitors.
    Mielicki WP; Tagawa M; Gordon SG
    Thromb Haemost; 1994 Apr; 71(4):456-60. PubMed ID: 8052963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variability in platelet procoagulant activity in healthy volunteers.
    Sumner WT; Monroe DM; Hoffman M
    Thromb Res; 1996 Mar; 81(5):533-43. PubMed ID: 8907312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic insight into the procoagulant activity of tumor-derived apoptotic vesicles.
    Muhsin-Sharafaldine MR; Kennedy BR; Saunderson SC; Buchanan CR; Dunn AC; Faed JM; McLellan AD
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):286-295. PubMed ID: 27864149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans-retinoic acid.
    Falanga A; Consonni R; Marchetti M; Mielicki WP; Rambaldi A; Lanotte M; Gordon SG; Barbui T
    Leukemia; 1994 Jan; 8(1):156-9. PubMed ID: 8289480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proaggregatory and procoagulant properties of three murine mammary gland tumor cell lines with different metastatic capabilities.
    Pasqualini ME; Ruiz Moreno L; Muñoz SE; Eynard AR
    Exp Toxicol Pathol; 1997 Dec; 49(5):403-7. PubMed ID: 9455689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of coagulation disorders and cancer procoagulant activity in patients with myelodysplastic syndromes.
    Chojnowski K; Treliński J; Wawrzyniak E; Sobolewska M; Mielicki W
    Neoplasma; 2002; 49(3):155-8. PubMed ID: 12098000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute lymphoblastic leukemia (ALL) and cancer procoagulant activity.
    Pogliani EM; Lanzafame C; Bucciarelli P; Corneo G
    Haematologica; 1991; 76(6):526-7. PubMed ID: 1688361
    [No Abstract]   [Full Text] [Related]  

  • 38. Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue.
    Gordon SG; Mielicki WP
    Blood Coagul Fibrinolysis; 1997 Mar; 8(2):73-86. PubMed ID: 9518049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of procoagulant activities in extracts of normal and malignant human tissue.
    Gordon SG; Franks JJ; Lewis BJ
    J Natl Cancer Inst; 1979 Apr; 62(4):773-6. PubMed ID: 285292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the procoagulant activity in the plasma of cancer patients using a thrombin generation assay.
    Debaugnies F; Azerad MA; Noubouossié D; Rozen L; Hemker HC; Corazza F; Efira A; Demulder A
    Thromb Res; 2010 Dec; 126(6):531-5. PubMed ID: 20870277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.